These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 15205916)

  • 21. Multiple congenital coagulopathies co-expressed with Von Willebrand's disease: the experience of Hemophilia Region III Treatment Centers over 25 years and review of the literature.
    Asatiani E; Kessler CM;
    Haemophilia; 2007 Nov; 13(6):685-96. PubMed ID: 17973844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical use of factor IX concentrates].
    Nyman D
    Schweiz Med Wochenschr; 1975 Sep; 105(37):1188-90. PubMed ID: 1215901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Off-pump myocardial revascularization in a diabetic patient with severe hemophilia B and impaired left ventricular function: hematological and operative strategies.
    Grandmougin D; Delolme MC; Reynaud J; Barral X
    J Card Surg; 2005; 20(4):366-9. PubMed ID: 15985141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver transplantation for a pediatric patient with hemophilia B.
    Sanada Y; Urahashi T; Ihara Y; Wakiya T; Okada N; Yamada N; Mizuta K
    Pediatr Transplant; 2012 Sep; 16(6):E193-5. PubMed ID: 22452579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant factor IX.
    White GC; Beebe A; Nielsen B
    Thromb Haemost; 1997 Jul; 78(1):261-5. PubMed ID: 9198163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant factor IX for the treatment of hemophilia B. Introduction.
    Thompson A
    Semin Hematol; 1998 Apr; 35(2 Suppl 2):1-3. PubMed ID: 9565159
    [No Abstract]   [Full Text] [Related]  

  • 27. Immune tolerance induction for a patient with factor IX inhibitors--a case report.
    Nagel K; Laudenbach L; Rivard GE; Jardine L; Chan AK; Pai MK
    Haemophilia; 2011 Mar; 17(2):315. PubMed ID: 20825499
    [No Abstract]   [Full Text] [Related]  

  • 28. Myocardial infarction after FEIBA therapy in a hemophilia-B patient with a factor IX inhibitor.
    Mizon P; Goudemand J; Jude B; Marey A
    Ann Hematol; 1992 Jun; 64(6):309-11. PubMed ID: 1637888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Association of von Willebrand's disease and factor IX deficiency in males and females of a family].
    Liñares Ruiz MS; Rodríguez Fernández JM
    Sangre (Barc); 1983; 28(6):782-91. PubMed ID: 6608799
    [No Abstract]   [Full Text] [Related]  

  • 30. Failure of immunosuppression in a severe haemophilia B patient with specific antibody.
    Allain JP; Frommel D
    Thromb Haemost; 1976 Aug; 36(1):86-9. PubMed ID: 1036830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Head trauma and hemophilia B: case report about a challenging hematologic emergency.
    Falcón-Chévere JL; Cabañas JG
    Bol Asoc Med P R; 2007; 99(4):318-22. PubMed ID: 18756646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serial changes in the coagulation system following clotting factor concentrate infusion.
    Preston FE; Winfield DA; Malia RG; Blackburn EK
    Thromb Diath Haemorrh; 1975 Nov; 34(2):475-82. PubMed ID: 1198408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disseminated intravascular coagulation in a patient with haemophilia B during factor IX replacement therapy.
    Ohga S; Saito M; Matsukazi A; Kai T; Ueda K
    Br J Haematol; 1993 Jun; 84(2):343-5. PubMed ID: 8398841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new drug form of blood coagulation factor IX: red blood cell-entrapped factor IX.
    Sinauridze EI; Vuimo TA; Kulikova EV; Shmyrev II; Ataullakhanov FI
    Med Sci Monit; 2010 Oct; 16(10):PI19-26. PubMed ID: 20885362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical and in vivo properties of high purity factor IX concentrates.
    Berntorp E; Björkman S; Carlsson M; Lethagen S; Nilsson IM
    Thromb Haemost; 1993 Nov; 70(5):768-73. PubMed ID: 8128433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A haemophilia B patient with severe burn injury: increased requirement for factor IX replacement therapy associated with venous thromboembolism.
    Yaish H; Rodgers GM
    Haemophilia; 2008 May; 14(3):607-9. PubMed ID: 18194306
    [No Abstract]   [Full Text] [Related]  

  • 37. Recombinant factor IX for clinical and research use.
    Monahan PE; Di Paola J
    Semin Thromb Hemost; 2010 Jul; 36(5):498-509. PubMed ID: 20632248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Factor IX inhibitor in hemophilia B presented with anaphylactoid symptoms: report of 3 cases].
    Taketani T; Hanada R; Kawaguchi H; Ida K; Yamamoto K
    Rinsho Ketsueki; 1999 Oct; 40(10):1124-6. PubMed ID: 10565232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preclinical studies of recombinant factor IX.
    Schaub R; Garzone P; Bouchard P; Rup B; Keith J; Brinkhous K; Larsen G
    Semin Hematol; 1998 Apr; 35(2 Suppl 2):28-32. PubMed ID: 9565164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracranial haemorrhage as initial presentation of severe haemophilia B: case report and review of Mayo Clinic Comprehensive Hemophilia Center experience.
    Rodriguez V; Schmidt KA; Slaby JA; Pruthi RK
    Haemophilia; 2005 Jan; 11(1):73-7. PubMed ID: 15660992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.